AlloCure's Series B - II Round

AlloCure raised a round of funding on December 23, 2013.

AlloCure is a biotechnology company developing the use of cell therapy for the treatment of kidney disease. AlloCure's technology allows for the isolation and expansion of a specific population of mes…

Articles about AlloCure's Series B - II Round: